BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 16455804)

  • 1. Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid.
    Tahara H; Kusuhara H; Maeda K; Koepsell H; Fuse E; Sugiyama Y
    Drug Metab Dispos; 2006 May; 34(5):743-7. PubMed ID: 16455804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organic anion transporters involved in the excretion of bestatin in the kidney.
    Zhu Y; Meng Q; Wang C; Liu Q; Sun H; Kaku T; Liu K
    Peptides; 2012 Feb; 33(2):265-71. PubMed ID: 22273603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters.
    Tahara H; Kusuhara H; Endou H; Koepsell H; Imaoka T; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2005 Oct; 315(1):337-45. PubMed ID: 16006492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of methotrexate transport and its drug interactions with human organic anion transporters.
    Takeda M; Khamdang S; Narikawa S; Kimura H; Hosoyamada M; Cha SH; Sekine T; Endou H
    J Pharmacol Exp Ther; 2002 Aug; 302(2):666-71. PubMed ID: 12130730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine.
    Liu S; Beringer PM; Hidayat L; Rao AP; Louie S; Burckart GJ; Shapiro B
    J Clin Pharmacol; 2008 Aug; 48(8):957-65. PubMed ID: 18511651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3.
    Uwai Y; Motohashi H; Tsuji Y; Ueo H; Katsura T; Inui K
    Biochem Pharmacol; 2007 Jun; 74(1):161-8. PubMed ID: 17462604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate.
    Mizuno N; Takahashi T; Iwase Y; Kusuhara H; Niwa T; Sugiyama Y
    Drug Metab Dispos; 2007 Aug; 35(8):1429-34. PubMed ID: 17502342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
    Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
    Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin and probenecid inhibit organic anion transporter 3-mediated renal uptake of cilostazol and probenecid induces metabolism of cilostazol in the rat.
    Wang C; Wang C; Liu Q; Meng Q; Cang J; Sun H; Peng J; Ma X; Huo X; Liu K
    Drug Metab Dispos; 2014 Jun; 42(6):996-1007. PubMed ID: 24692216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal organic anion transporter-mediated drug-drug interaction between gemcabene and quinapril.
    Yuan H; Feng B; Yu Y; Chupka J; Zheng JY; Heath TG; Bond BR
    J Pharmacol Exp Ther; 2009 Jul; 330(1):191-7. PubMed ID: 19349522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport of the natural sweetener stevioside and its aglycone steviol by human organic anion transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8).
    Srimaroeng C; Chatsudthipong V; Aslamkhan AG; Pritchard JB
    J Pharmacol Exp Ther; 2005 May; 313(2):621-8. PubMed ID: 15644426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal organic anion transporters OAT1 and OAT3 mediate the cellular accumulation of 5-sulfooxymethylfurfural, a reactive, nephrotoxic metabolite of the Maillard product 5-hydroxymethylfurfural.
    Bakhiya N; Monien B; Frank H; Seidel A; Glatt H
    Biochem Pharmacol; 2009 Aug; 78(4):414-9. PubMed ID: 19394312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics.
    Yasui-Furukori N; Uno T; Sugawara K; Tateishi T
    Clin Pharmacol Ther; 2005 Jan; 77(1):17-23. PubMed ID: 15637527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the uptake of organic anion transporter (OAT) 1 and OAT3 substrates by human kidney slices.
    Nozaki Y; Kusuhara H; Kondo T; Hasegawa M; Shiroyanagi Y; Nakazawa H; Okano T; Sugiyama Y
    J Pharmacol Exp Ther; 2007 Apr; 321(1):362-9. PubMed ID: 17255469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans.
    Maeda K; Tian Y; Fujita T; Ikeda Y; Kumagai Y; Kondo T; Tanabe K; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
    Eur J Pharm Sci; 2014 Aug; 59():94-103. PubMed ID: 24747579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human organic anion transporter 3 mediated pravastatin transport by gemfibrozil and the metabolites in humans.
    Nakagomi-Hagihara R; Nakai D; Tokui T
    Xenobiotica; 2007 Apr; 37(4):416-26. PubMed ID: 17455113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs.
    Cheng Y; Vapurcuyan A; Shahidullah M; Aleksunes LM; Pelis RM
    Drug Metab Dispos; 2012 Mar; 40(3):617-24. PubMed ID: 22190696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of chemically reactive, DNA-damaging sulfuric acid esters into renal cells by human organic anion transporters.
    Bakhiya N; Stephani M; Bahn A; Ugele B; Seidel A; Burckhardt G; Glatt H
    J Am Soc Nephrol; 2006 May; 17(5):1414-21. PubMed ID: 16597690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of human multidrug and toxin extrusion 1 is involved in the drug-drug interaction caused by cimetidine.
    Matsushima S; Maeda K; Inoue K; Ohta KY; Yuasa H; Kondo T; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2009 Mar; 37(3):555-9. PubMed ID: 19074525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).
    Uwai Y; Ida H; Tsuji Y; Katsura T; Inui K
    Pharm Res; 2007 Apr; 24(4):811-5. PubMed ID: 17372702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.